NCT07085130

Brief Summary

The study will be conducted to determine the effect of cold application and virtual reality (VR) or combined hand and foot exercises on pain intensity, kinesiophobia, and fragility levels in patients with diabetic peripheral neuropathy.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 25, 2025

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

July 11, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

July 25, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 25, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 25, 2025

Completed
Last Updated

July 25, 2025

Status Verified

July 1, 2025

Enrollment Period

6 months

First QC Date

July 11, 2025

Last Update Submit

July 24, 2025

Conditions

Keywords

diabetic peripheral neuropathyhand and foot exercisescold applicationvirtual realitykinesiophobiafrailityneuropatic pain

Outcome Measures

Primary Outcomes (3)

  • Changes in kinesiophobia

    As a result of the intervention, the Tampa Kinesiophobia Scale will be used to evaluate the differences and effects between the intervention and control groups in terms of fear of movement levels. The Turkish validity and reliability study of the scale developed by Miller and colleagues (1991) was conducted by Yılmaz and colleagues (2011). The TKÖ is a 17-item scale developed to measure fear of movement/re-injury. Each question in the scale uses a 4-point Likert scale (1 = Strongly disagree, 2 = Disagree, 3 = Neither agree nor disagree, 4 = Strongly agree). The total score obtained from the questionnaire ranges from 17 to 68. A high score on the scale indicates a high level of kinesiophobia.

    At the end of eight weeks

  • Change in the neuropathic pain levels

    Following an eight-week intervention, the Douleur Neuropathique en 4-DN4 questionnaire will be used to assess whether there has been a reduction in patients' neuropathic pain levels. The DN4 pain questionnaire, developed by a neuropathic pain group, consists of four questions that inquire about the characteristics, type, location, and aggravating factors of neuropathic pain. According to the scale, neuropathic pain is assessed with a total of four questions, the first two of which are based on direct interviews with the patient and the last two on the patient's clinical examination. The Turkish validity and reliability study was conducted by Ünal Çevik and colleagues (2010). The questions in the questionnaire are answered with "yes" or "no." Each 'yes' answer is scored as 1 point, and each "no" answer is scored as 0 points. According to the scale, the threshold value for neuropathic pain is set at 4/10 or higher.

    at the end of eight weeks

  • Change in fraility

    As a result of the intervention, the fragility levels of patients with diabetic peripheral neuropathy will be assessed using the Tilburg Fraility Scale. The Turkish validity and reliability study of the scale developed by Gobbens and colleagues (2010) was conducted by Arslan and colleagues (2018). The TKÖ consists of 15 questions and 3 sub-dimensions that assess vulnerability. The scale includes 8 questions that assess the physical domain, 4 questions that assess the psychological domain, and 3 questions that assess the social domain. Eleven items of the TKÖ are evaluated in two categories: "Yes" and "No." Four items of the TKÖ are scored as "yes," "sometimes," and "no." The total score that can be obtained from the scale ranges from 0 to 15, with scores of 5 and above indicating the presence of vulnerability.

    At the end of eight weeks

Study Arms (4)

Intervention: Cold Application

EXPERIMENTAL

Patients in the cold application intervention group will be evaluated during the first week and data collection forms will be completed. They will perform the hand and foot exercises in the exercise video three days a week, after which cold compress bags will be applied to their hands and feet for 5-10 minutes. They will be cooled to -25 to -30 °C for at least 3 hours before use.

Behavioral: Exercises and cold application

Intervention: Virtual Reality

EXPERIMENTAL

Patients in the virtual reality intervention group will be evaluated during the first week and data collection forms will be completed. The virtual reality application will be taught through explanation and demonstration. The researcher will accompany the patients and the glasses and headphones will be put on the patient in a comfortable sitting position. As part of the application, patients will attempt to perform hand and foot exercises for an average of 15 minutes in a virtual environment accompanied by snowy landscapes and snow-themed sounds. The patient will be observed by the researcher during the application, and if symptoms such as dizziness, headache, or discomfort occur during the virtual reality application, the application will be terminated. Patients in the virtual reality intervention group will perform the virtual reality application three times a week for eight weeks. Patients will record their virtual reality applications in the Virtual Reality Application Diary.

Other: Exercises and virtual reality

Control

NO INTERVENTION

Patients in the control group will be allocated time similar to the intervention flow applied to the intervention groups, and diabetic peripheral neuropathy will be explained. In this context, the control group patients will be evaluated in the first week, data collection forms will be filled out, and neuropathy management training will be explained by the researcher. The content of the presentation will cover the treatment and management of diabetic neuropathy.

Intervention: Hand and foot exercises

EXPERIMENTAL

In this study, hand and foot exercises will be combined with both cold application and virtual reality, and both intervention groups will perform these exercises. Patients will perform hand and foot exercises approximately three times a week for about 15 minutes. Hand and foot exercises are an easy-to-perform, low-cost type of exercise designed to relieve individuals who experience numbness and tingling-like pain. Patients will perform hand movements such as the snail movement, making a full and half fist, the claw movement, and rolling a ball. For foot exercises, they will perform movements such as crumpling a towel, rolling a ball, and spreading the toes.

Behavioral: Exercises and cold applicationOther: Exercises and virtual reality

Interventions

Hand and foot exercises combined with cold application interventions are non-pharmacological methods used to reduce pain, kinesiophobia, and fragility levels in patients with diabetic peripheral neuropathy.

Also known as: cold application, hand and foot exercises
Intervention: Cold ApplicationIntervention: Hand and foot exercises

Performing hand and foot exercises in a cold, snowy virtual environment using virtual reality goggles may be a non-pharmacological intervention to alleviate burning-type hand and foot pain in patients with diabetic neuropathy.

Also known as: virtual reality, hand and foot exercises
Intervention: Hand and foot exercisesIntervention: Virtual Reality

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Those who volunteer to participate in the study
  • Those who have been diagnosed with diabetes at least 6 months ago
  • Those who show symptoms of neuropathy
  • Those over the age of 18
  • Those without cognitive or psychiatric diagnoses
  • Those who are open to communication and cooperation
  • Those who use a smartphone

You may not qualify if:

  • Those with neurological disorders other than neuropathy
  • Those with any additional orthopedic or systemic disorders that would prevent them from performing the exercises
  • Those who have had a lower extremity pathology (surgery, fracture, soft tissue injury, etc.) in the past 6 months
  • Those who are pregnant during the study period
  • Those who wish to withdraw from the study of their own accord

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sakarya University

Sakarya, Serdivan, 54050, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Kinesiophobia

Interventions

ExerciseExergaming

Condition Hierarchy (Ancestors)

Phobic DisordersAnxiety DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Busra Gurcay, Research Assistant

    Sakarya University Health Science Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: In terms of the reliability of the study results, patients in this study will be divided into groups using a stratified randomization method. Patients will be randomly assigned to two intervention (I) and one control (C) groups according to their age.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 11, 2025

First Posted

July 25, 2025

Study Start

June 25, 2025

Primary Completion

December 25, 2025

Study Completion

December 25, 2025

Last Updated

July 25, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations